News & Events

Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.

Isogenica’s

Latest News

PRESS RELEASES

Isogenica-Phenotypeca SMART Grant Collaboration

Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award  Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions...

Announcements

Catch up on Isogenica’s latest activities.

Accelerating antibody discovery with machine learning

A collaboration with the University of Nottingham and Aston University  Advances in computing and data science, such as machine learning (ML) and artificial intelligence (AI), are transforming all...

CHI Sixth Annual Immuno-Oncology Summit Europe

Join Isogenica in London at the Annunal Immuno-Oncology SummitThe Isogenica team will be attending in person at CHI's annual Immuno-Oncology conference, taking place on 23rd-25th May....

Webinars

Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.

Nature Webinar

Register for Isogenica's upcoming webinar Join Isogenica for the upcoming webinar with Nature on 'VHH as building blocks for immune and tumour cell-targeting', presented by Isogenica's CSO Bill...

Resources

Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.

VHH antibodies as biotherapeutics

Camelid heavy-chain only antibodies were discovered in the early 1990’s. Often referred to as VHH antibodies, they are a well characterized alternative to therapeutic IgG’s. Camelid heavy-chain only...

read more